WO2026021557 - PHARMACEUTICAL COMPOSITION OF BENZINDOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/021557
Publication Date
29.01.2026
International Application No.
PCT/CN2025/110492
International Filing Date
25.07.2025
Title **
[English]
PHARMACEUTICAL COMPOSITION OF BENZINDOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
COMPOSITION PHARMACEUTIQUE D'UN DÉRIVÉ DE BENZINDOLE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
苯并吲哚衍生物的药物组合物、制备方法及用途
Applicants **
SHANGHAI HELIOSON PHARMACEUTICAL CO.
Inventors
ZHAO, Liwen
ZHANG, Kefeng
XU, Zheng
WANG, Dihuang
Priority Data
202411015044.1
26.07.2024
CN
202411315301.3
20.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1661 | |
| EPO | Filing, Examination, Granting | 11551 | |
| Japan | Filing, Examination, Granting | 2030 | |
| South Korea | Filing, Examination, Granting | 1900 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,882
Contact Us
Abstract[English]
The present application relates to the technical field of pharmaceutical formulations and particularly to a pharmaceutical composition of a benzindole derivative, a preparation method therefor, and use thereof. The pharmaceutical composition comprises a compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient, and one or more pharmaceutically acceptable excipients. The active ingredient in the pharmaceutical composition demonstrates good dissolution and excellent absorption in an organism, and the pharmaceutical composition remains stable even during long-term storage.[French]
La présente invention concerne le domaine technique des formulations pharmaceutiques et en particulier une composition pharmaceutique d'un dérivé de benzindole, son procédé de préparation et son utilisation. La composition pharmaceutique comprend un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif, et un ou plusieurs excipients pharmaceutiquement acceptables. Le principe actif dans la composition pharmaceutique présente une bonne dissolution et une excellente absorption dans un organisme, et la composition pharmaceutique reste stable même pendant un stockage à long terme.[Chinese]
本申请涉及药物制剂技术领域，具体涉及一种苯并吲哚衍生物的药物组合物、制备方法及用途；所示药物组合物包括活性成分式（I）所示化合物或其药学上可接受的盐以及一种或多种药学上可接受的辅料；所述药物组合物中活性成分溶出性好，在生物体内的吸收性优异，药物组合物即使长期保存也稳定。